Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Policy & Regulation
Trends & Finance
Payor Coverage: Page 5
CVS Health paves way for genetic testing of cancer patients
By
LabPulse.com staff writers
The program -- dubbed Transform Oncology Care -- revolves around a web-based prescribing portal that will direct oncologists to gene panel testing through partner Tempus, which provides a broad range of DNA and RNA sequencing services. It will be enabled through the company's CVS Caremark pharmacy benefit manager subsidiary and is now open to patients enrolled in Aetna commercial insurance plans in 12 U.S. states. The program will also be marketed to other insurance companies.
December 11, 2019
Disability agency urges crackdown on prenatal genetic testing
By
Rishbha Bhagi
The NCD, which is an independent government agency charged with advising policymakers, examined the effects of genetic testing on disabled communities and analyzed the various factors that influence prenatal genetic testing. Its findings were published in the report, titled "Genetic Testing and the Rush to Perfection," on October 23.
October 30, 2019
New AncestryHealth features physician-ordered tests in CLIA labs
By
LabPulse.com staff writers
The company's new AncestryHealth tests will complement its long-running AncestryDNA genealogy services. Health testing will be ordered by physicians and performed by independent CLIA-certified laboratories, the company noted in a statement. To complement testing, Ancestry will provide genetic counseling and other educational resources, along with reports that suggest how to act on the findings in consultation with health professionals. The new offerings may be accessed on a one-time basis or as part of a regular subscription service.
October 14, 2019
Insurance claims study makes case for more prenatal blood testing
By
LabPulse.com staff writers
In the real-world study of claims data, Harvard Pilgrim Health Care and Illumina worked together to dramatically expand the use of prenatal blood testing to younger pregnant women while reducing the number of invasive tests, such as amniocentesis.
October 9, 2019
OncoCyte set to buy Razor, reveals plans for lung cancer tests
By
LabPulse.com staff writers
The Razor Genomics molecular prognostic assay is designed to assess risk of recurrence following the resection of early-stage, nonsquamous non-small cell lung cancer. The test received a positive initial coverage decision in August from the U.S. Centers for Medicare and Medicaid Services (CMS), which should pave the way for reimbursement.
September 5, 2019
AACC: How not to fail your lab inspection
By
Emily Hayes
More than 8,000 labs are accredited on a voluntary basis by the Northfield, IL-based College of American Pathologists (CAP) and must meet particular requirements for proficiency testing. In June, the organization published a list of 41 labs that had been continuously accredited since 1964. CAP may provide inspections instead of the U.S. Centers for Medicare and Medicaid Services (CMS), which has an oversight role for labs through CLIA.
August 7, 2019
Freenome reels in $160M for cancer blood testing
By
LabPulse.com staff writers
Including the latest financing round -- led by RA Capital Management and Polaris Partners -- the company has raised a total of $238Â million.
July 25, 2019
CAP showcases labs accredited for over 50 years
By
LabPulse.com staff writers
CAP noted that the program helps labs comply with regulations from the U.S. Centers for Medicare and Medicaid Services (CMS), which has an oversight role through the Clinical Laboratory Improvement Amendments (CLIA) of 1988. Accreditation includes onsite checks by laboratory peer inspectors every two years and compliance with quality and procedural checklists that are regularly updated. Through CAP accreditation, labs may also show that they are keeping up to date with new technologies in the pathology field, such as information technology, artificial intelligence, and liquid biopsies.
June 23, 2019
New world order for STD tests | Red flags on CLIA-waived products | FDA's burst of preholiday actions
By
Emily Hayes
Dear LabPulse Member,
May 27, 2019
Welcome to LabPulse | Molecular profiling for genetic mutations | EHR for GIPP | CMS opens NGS review
By
Emily Hayes
Dear LabPulse Member,
April 29, 2019
Previous Page
Page 5 of 5